The reduced GCase enzymatic activity of the GBA1 mutation (WT/N370S) PD neurons would be expected to lower levels of ceramide, which would in turn lead to a lower level of CSTD protein with lower enzymatic activity. This evidence concerns the gene GBA1 and Parkinson disease.